Brands and Products
Chemours uses the power of chemistry to create better, reliable solutions.
Connectivity and Advanced Electronics
Our cell phones, the Internet of Things, advanced electronics, the 5G revolution, and even semiconductors are enabled by Chemours chemistry.
Corporate Responsibility
Creating a better world through responsible chemistry.
Our 2030 Goals
Our progress toward achieving Chemours’ Corporate Responsibility Commitment goals.
Critical Chemistries
Chemours is working to create a better world through the power of our chemistry.
Showing 1-10 of 18 results for "R142b"
Vertrel™ specialty fluids act as fluorinated solvents, cleaners, and more.
Full Year 2018 Highlights Net Sales of $6.6 billion, up 7% Net Income of $995 million, up 33%, with EPS of $5.45, up 39% Adjusted Net Income of $1.0 billion, up 42%, with Adjusted EPS of $5.67, up 48% Adjusted EBITDA of $1.7 billion, up 22% Returned over $790 million to shareholders through share repurchases and dividends Fourth Quarter 2018 Highlights Net Sales of $1.5 billion Net Income of $142 ...
First Quarter 2017 Highlights Net Sales of $1.4 billion , up 11%, including impacts from divestitures Net Income of $150 million , up $99 million with EPS of $0.79 , up $0.51 per diluted share Adjusted EBITDA of $285 million , up 123%, demonstrating margin improvement across all segments Adjusted Net Income of $142 million , up $131 million with Adjusted EPS of $0.75 , up $0.69 per diluted share A...
Documents have been submitted by The Chemours Company.
We are committed to taking a leadership role in environmental stewardship.
Second Quarter 2017 Highlights Net Sales of $1.6 billion , up 15% Net Income of $161 million , up $179 million with EPS of $0.84 , up $0.94 per diluted share Adjusted EBITDA of $361 million , up $174 million , driven by strong year-over-year volume and price improvement in Titanium Technologies and Fluoroproducts Adjusted Net Income of $166 million , up $117 million with Adjusted EPS of $0.87 , up...
Continuing to Aggressively Return Capital to Shareholders First Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $94 million, with EPS of $0.55 Adjusted Net Income of $109 million, with Adjusted EPS of $0.63 Adjusted EBITDA of $262 million Returned $261 million to shareholders through share repurchases The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leadi...
Vertrel™ XSi is specially designed for use in the medical industry.
Full Year 2019 Results In-line with Updated Guidance Full Year 2019 Results Net Sales of $5.5 billion Net Income of $(52) million with EPS of $(0.32) Adjusted Net Income of $419 million with Adjusted EPS of $2.51 Adjusted EBITDA of $1.02 billion Free Cash Flow of $169 million Returned $486 million to shareholders through share repurchases and dividends Fourth Quarter 2019 Results Net Sales of $1.4...
Committed to Core Growth Strategy Despite Near Term Headwinds Second Quarter 2019 Highlights Net Sales of $1.4 billion Net Income of $96 million, with diluted EPS of $0.57 Adjusted Net Income of $120 million, with diluted Adjusted EPS of $0.72 Adjusted EBITDA of $283 million Returned $108 million to shareholders through share repurchases and dividends Other Highlights Completed the acquisition of ...
Use our database to access product SDS.
Chemours delivers valuable solutions to various industries around the globe.
The world depends on the power of chemistry.